Loading...
Sharps Technology, Inc.
STSS•NASDAQ
Healthcare
Medical - Instruments & Supplies
$10.35
$2.99(40.72%)

The company's financials show resilient growth, with revenue advancing from -$8226.00 in Q4 2023 to $0.00 in Q3 2024. Gross profit remained healthy with margins at N/A in Q3 2024 compared to 2946% in Q4 2023. Operating income hit -$2.02M last quarter, sustaining a consistent N/A margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$2.02M. Net income rose to -$1.69M, while earnings per share reached -$1.27. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan